Related Experiment Video

Updated: Mar 9, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K

Advances in Cardiac Biomarkers of Acute Coronary Syndrome

A K Saenger1, N Korpi-Steiner2

  • 1University of Minnesota, Minneapolis, MN, United States.

Advances in Clinical Chemistry
|January 7, 2017
PubMed

Insights

Acute coronary syndrome (ACS) is now viewed as both acute and chronic, thanks to new treatments and high-sensitivity cardiac troponin (hs-cTn) assays. Understanding hs-cTn assay performance is key for accurate diagnosis and improved patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Biomarker Development

Background:

  • Acute coronary syndrome (ACS) presents significant morbidity and mortality.
  • Historically viewed as acute, ACS is now recognized as having chronic implications due to treatment advances.
  • Cardiac troponin is the gold standard biomarker for diagnosing myocardial infarction.

Purpose of the Study:

  • To review the analytical and clinical performance of high-sensitivity cardiac troponin (hs-cTn) assays.
  • To highlight the importance of understanding hs-cTn assay limitations for appropriate clinical use.
  • To explore the expanding utility of hs-cTn assays in diverse patient populations.

Main Methods:

  • Review of current literature on hs-cTn assay performance.
  • Analysis of clinical data regarding hs-cTn assay application.
  • Discussion of testing limitations and future directions for hs-cTn assays.

Main Results:

  • High-sensitivity cardiac troponin (hs-cTn) assays are increasingly implemented globally.
  • Understanding assay characteristics is crucial for accurate diagnosis and management of ACS.
  • hs-cTn assays show potential for improved prognostication in various clinical settings.

Conclusions:

  • hs-cTn assays are vital tools in modern cardiovascular diagnostics.
  • Appropriate utilization of hs-cTn assays can enhance patient care and outcomes.
  • Further research into hs-cTn assay applications in broader populations is warranted.

Keywords:
Acute coronary syndromeBiomarkerChest painHigh-sensitivity troponinMyocardial infarctionTroponin

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

17.2K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
681
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
596
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
433